1.
The Effect of Activition of Coagulation Cascade Mediated by Protease-activated Receptors(PARs) in Sepsis;
蛋白酶激活受体介导的凝血激活在脓毒症中的作用
2.
Clinical Research on Activation of Platelet and Prothrombin after Transcatheter Closure of Atrial Septal Defects;
房间隔缺损封堵术后血小板活化和凝血酶原激活临床研究
3.
Studies on the Thrombin Activatable Fibrinolysis Inhibitor of Coronary Atherosclerotic Heart Disease;
冠心病患者凝血酶激活的纤溶抑制物研究
4.
Relationship between Thrombin Activated Fibrinolysis Inhibitor in Plasma and Vascular Complication in Type 2 Diabetes;
血浆凝血酶激活的纤溶抑制物与2型糖尿病血管并发症的关系
5.
When activated, platelets release their granules to promote coagulation, change shape, and become sticky to aggregate and plug small vascular holes.
当血小板被激活时它会释放颗粒以促进血小板凝固并改变其形状使血小板凝固起来阻塞血管。
6.
Study of the Relativity between Thrombin-activatable Fibrinolysis Inhibtor and Stroke
血浆凝血酶激活的纤溶抑制物与脑卒中的相关性研究
7.
The Relationship between Thrombin-Activatable Fibrinolysis Inhibitor and Risk of Stroke
血浆凝血酶激活的纤溶抑制物与脑卒中的相关性
8.
The clinical study of plasma thrombin activatable fibrinolysis inhibitor in the patients with stroke
脑卒中患者血浆凝血酶激活的纤溶抑制物的临床研究
9.
Influence of Aprotinin to Activated Clotting Time and Whole Blood Prothrombin Time during Cardiopulmonary Bypass;
体外循环下抑肽酶对激活的全血凝固时间和全血凝血酶原时间的影响
10.
This can activate platelets and the clotting system, which in turn slows blood flow.
它能导致突发高血压和血流不规则，进而激活血小板和凝血系统，并进一步降低血流速度。
11.
Effects of Thrombin-activable Fibrinolysis Inhibitor and Hirudin on Fibrinolysis;
凝血酶激活的纤溶抑制剂与水蛭素对纤溶的影响
12.
Nucleocapsid Protein of SARS-associated Coronavirus Upregulates the Transcription of hfgl2 Prothrombinase/ Fibroleukin Gene;
SARS冠状病毒N蛋白激活hfgl2凝血酶原酶基因的研究
13.
A Study of Relation between Thrombin Activatable Fi Brinolysis Inhibition and Coronary Heart Disease.;
凝血酶激活的纤溶抑制物与冠心病的相关性研究
14.
Analysis of the Relationship Between Thrombin Activatable Fibrinolysis Inhibitor and Fibrinogen in Patients with Coronary Atherosclerotic Heart Disease
冠心病患者凝血酶激活的纤溶抑制物与纤维蛋白原关系分析
15.
Electrophysiological evaluation of the safety of injection of tissue plasminogen activator into optic nerve in rabbits
视盘内注射组织凝血酶原激活剂安全性的电生理学评价(英文)
16.
Genetic polymorphism of thrombin-activatable fibrinolysis inhibitor(TAFI) associated with type 2 diabetes mellitus
凝血酶激活的纤溶抑制物编码区基因多态性与2型糖尿病的关系
17.
tissue thromboplasti
组织促凝血酶原激酶
18.
thromboplastin antecedent
促凝血酶原激酶先质